Cathay Biotech Inc. (SHA:688065)
China · Delayed Price · Currency is CNY 39.03
-0.18 (-0.46%)
Nov 6, 2026, 3:00 PM CST
Cathay Biotech Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,588 | 3,295 | 2,958 | 2,114 | 2,441 | 2,363 |
Revenue Growth | 9.13% | 11.40% | 39.91% | -13.39% | 3.28% | 57.86% |
Gross Profit Gross Profit Growth | 1,091 | 991.2 | 836.44 | 579.23 | 829.2 | 837.21 |
Operating Income Operating Income Growth | 616.84 | 526.78 | 396.1 | 165.55 | 406.61 | 499.25 |
Net Income Net Income Growth | 637 | 560.72 | 488.96 | 366.52 | 553.27 | 594.72 |
Earnings Per Share EPS Growth | 0.88 | 0.82 | 0.84 | 0.63 | 0.95 | 1.02 |
EPS Growth | -3.68% | -2.38% | 33.33% | -33.68% | -6.86% | 21.01% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Biological Long-Chain Dibasic Acid Biological Long-Chain Dibasic Acid Growth | 2,935 |
Bio-Based Polyamide Bio-Based Polyamide Growth | 127.41 |
Others Others Growth | 57.84 |
Total Total Growth | 3,120 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 8,774 | 9,252 | 5,347 | 5,391 | 6,295 | 9,629 |
Total Debt Total Debt Growth | 890.83 | 503 | 1,897 | 1,776 | 1,127 | 743.51 |
Net Cash (Debt) Net Cash Growth | 7,884 | 8,749 | 3,450 | 3,615 | 5,168 | 8,886 |
Net Cash Growth | -9.68% | 153.60% | -4.56% | -30.05% | -41.84% | 26.22% |
Net Cash Per Share Net Cash Per Share Growth | 10.94 | 12.79 | 5.93 | 6.21 | 8.87 | 15.24 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 747.64 | 404.12 | 820.93 | 569.45 | 803.67 | 578.69 |
Capital Expenditures CapEx Growth | -1,033 | -743.46 | -843.31 | -1,570 | -4,198 | -1,459 |
Free Cash Flow Free Cash Flow Growth | -285.43 | -339.34 | -22.38 | -1,000 | -3,395 | -880.49 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 30.41% | 30.08% | 28.28% | 27.40% | 33.97% | 35.42% |
Operating Margin | 17.19% | 15.99% | 13.39% | 7.83% | 16.66% | 21.12% |
Pretax Margin | 20.39% | 19.12% | 18.53% | 21.23% | 28.51% | 30.65% |
Profit Margin | 17.75% | 17.02% | 16.53% | 17.34% | 22.66% | 25.16% |
FCF Margin | -7.95% | -10.30% | -0.76% | -47.32% | -139.06% | -37.25% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.450 | 0.450 | 0.400 | 0.190 | 0.180 | 0.321 |
Dividend Per Share Growth | 12.50% | 12.50% | 110.53% | 5.56% | -43.99% | -43.75% |
Dividend Yield | 1.15% | 0.90% | 1.03% | 0.34% | 0.29% | 0.24% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 44.16 | 64.01 | 46.13 | 87.34 | 64.61 | 129.11 |
Forward PE | 34.58 | 48.47 | 29.61 | 46.74 | 38.31 | 89.61 |
PS Ratio | 7.84 | 10.89 | 7.63 | 15.14 | 14.65 | 32.49 |